Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

September 01, 1962; Volume 137,Issue 3

Articles

  • You have access
    OBSERVATIONS ON THE FREQUENCY DEPENDENCE OF SYMPATHETIC GANGLION BLOCKADE
    William K. Riker and A. Komalahiranya
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 267-274;
  • You have access
    THE CARDIOVASCULAR PHARMACOLOGY OF t-BUTYLAMINE
    Thomas Baum, Kent R. Hornbrook, Hector Vasquez-Leon and Donald R. Bennett
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 275-284;
  • You have access
    BULBOCAPNINE: AN ADRENERGIC AND SEROTONIN BLOCKING AGENT
    Edward J. Walaszek and John E. Chapman
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 285-290;
  • You have access
    THE ACTION OF DICHLOROISOPROTERENOL (DCI) AND SEVERAL OTHER PHARMACOLOGICAL AGENTS UPON THE ACONITINE-INDUCED VENTRICULAR ARRHYTHMIA IN THE ISOLATED RABBIT HEART
    Benedict R. Lucchesi
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 291-300;
  • You have access
    THE ROLE OF MYOCARDIAL CATECHOLAMINES IN THE RESPONSE TO TYRAMINE
    Thomas E. Gaffney, Dean H. Morrow and Charles A. Chidsey
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 301-305;
  • You have access
    STUDIES ON VERATRUM ALKALOIDS. XXXIV. ACTIONS OF VERATRAMINE ON SPONTANEOUSLY BEATING GUINEAPIG ATRIUM PREPARATIONS
    D. F. Hawkins
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 306-312;
  • You have access
    STUDIES ON THE RESPIRATORY AND CARDIOVASCULAR EFFECTS OF (-)-COTININE
    Joseph F. Borzelleca, Edward R. Bowman and Herbert McKennis
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 313-318;
  • You have access
    EFFECT OF HYDROCHLOROTHIAZIDE ON RENAL ELECTROLYTE GRADIENT IN GLUCOSE DIURESIS AND EXPERIMENTAL DIABETES INSIPIDUS
    J. E. Baer, A. V. Brooks, R. M. Noll and Karl H. Beyer
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 319-323;
  • You have access
    INVOLVEMENT OF THE DISTAL TUBULE IN DIURESIS PRODUCED BY BENZOTHIADIAZINES
    E. J. Cafruny and Charles Ross
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 324-328;
  • You have access
    EFFECTS OF AN INHIBITOR OF THE CHOLINESTERASE SYSTEM OF BRAIN AND CEREBROSPINAL FLUID
    Malcolm B. Bowers and George W. Ketner
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 329-333;
  • You have access
    NEUROLOGIC, NEUROPATHOLOGIC, AND NEUROCHEMICAL EFFECTS OF PROLONGED ADMINISTRATION OF PHENYLISOPROPYLHYDRAZINE (JB 516), PHENYLISOBUTYLHYDRAZINE (JB 835), AND OTHER MONOAMINE OXIDASE INHIBITORS
    H. M. Maling, B. Highman and S. Spector
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 334-343;
  • You have access
    NEUROPATHOLOGIC LESIONS IN DOGS AFTER PROLONGED ADMINISTRATION OF PHENYLISOPROPYLHYDRAZINE (JB 516) AND PHENYLISOBUTYLHYDRAZINE (JB 835)
    Benjamin Highman and Harriet M. Maling
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 344-355;
  • You have access
    CENTRAL EFFECTS OF β3-PHENYLISOPROPYLHYDRAZINE AND IPRONIAZID
    Angelo R. Furgiuele, William J. Kinnard and Joseph P. Buckley
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 356-360;
  • You have access
    SOME DETERMINANTS OF AMPHETAMINE TOXICITY IN AGGREGATED MICE
    Gregory B. Fink and Robert E. Larson
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 361-364;
  • You have access
    CHLORPHENTERMINE, A NEW ANORECTIC AGENT
    J. A. Gylys, J. J. D. Hart and M. R. Warren
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 365-373;
  • You have access
    THE EFFECT OF ANABOLIC STEROIDS ON DRUG METABOLISM BY MICROSOMAL ENZYMES IN RAT LIVER
    Joan Booth and James R. Gillette
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 374-379;
  • You have access
    ON THE EFFECT OF TRIPARANOL ON THE ADRENAL CORTEX OF THE RAT: A HISTOCHEMICAL STUDY
    A. Eisalo and S. Talanti
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 380-386;
  • You have access
    EFFECT OF DIETARY PHENYLALANINE AND TRYPTOPHAN UPON RAT BRAIN AMINE LEVELS
    Harry Green, Samuel M. Greenberg, Robert W. Erickson, John L. Sawyer and Theodore Ellison
    Journal of Pharmacology and Experimental Therapeutics September 1962, 137 (3) 386;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 137, Issue 3
1 Sep 1962
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics